These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 8735675

  • 1. Rebuilding confidence in oral contraceptives: a new imperative in family planning.
    Spitzer WO.
    Br J Clin Pharmacol; 1996 May; 41(5):359-63. PubMed ID: 8735675
    [Abstract] [Full Text] [Related]

  • 2. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR.
    Lancet; 1997 Jan 11; 349(9045):83-8. PubMed ID: 8996419
    [Abstract] [Full Text] [Related]

  • 3. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
    Lewis MA, Heinemann LA, Spitzer WO, MacRae KD, Bruppacher R.
    Contraception; 1997 Sep 11; 56(3):129-40. PubMed ID: 9347202
    [Abstract] [Full Text] [Related]

  • 4. Modern oral contraceptives and cardiovascular disease.
    Rosenberg L, Palmer JR, Sands MI, Grimes D, Bergman U, Daling J, Mills A.
    Am J Obstet Gynecol; 1997 Sep 11; 177(3):707-15. PubMed ID: 9322646
    [Abstract] [Full Text] [Related]

  • 5. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
    Carr BR, Ory H.
    Contraception; 1997 May 11; 55(5):267-72. PubMed ID: 9220222
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Oral contraceptives: APF takes a position].
    Sex Planeam Fam; 1995 May 11; (7):17-8. PubMed ID: 12179267
    [Abstract] [Full Text] [Related]

  • 8. Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts?
    Contracept Rep; 1996 Apr 11; 7(1):3-6. PubMed ID: 12320047
    [Abstract] [Full Text] [Related]

  • 9. First-time use of newer oral contraceptives and the risk of venous thromboembolism.
    Suissa S, Blais L, Spitzer WO, Cusson J, Lewis M, Heinemann L.
    Contraception; 1997 Sep 11; 56(3):141-6. PubMed ID: 9347203
    [Abstract] [Full Text] [Related]

  • 10. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women.
    Heinemann LA, Lewis MA, Thorogood M, Spitzer WO, Guggenmoos-Holzmann I, Bruppacher R.
    BMJ; 1997 Dec 06; 315(7121):1502-4. PubMed ID: 9420491
    [Abstract] [Full Text] [Related]

  • 11. Oral contraceptives and myocardial infarction: results of the MICA case-control study.
    Dunn N, Thorogood M, Faragher B, de Caestecker L, MacDonald TM, McCollum C, Thomas S, Mann R.
    BMJ; 1999 Jun 12; 318(7198):1579-83. PubMed ID: 10364115
    [Abstract] [Full Text] [Related]

  • 12. Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives.
    Schwingl PJ, Shelton J.
    Contraception; 1997 Mar 12; 55(3):125-9. PubMed ID: 9114999
    [Abstract] [Full Text] [Related]

  • 13. Myocardial infarction and stroke in young women: what is the impact of oral contraceptives?
    Lewis MA.
    Am J Obstet Gynecol; 1998 Sep 12; 179(3 Pt 2):S68-77. PubMed ID: 9753313
    [Abstract] [Full Text] [Related]

  • 14. Bias versus causality: interpreting recent evidence of oral contraceptive studies.
    Spitzer WO.
    Am J Obstet Gynecol; 1998 Sep 12; 179(3 Pt 2):S43-50. PubMed ID: 9753310
    [Abstract] [Full Text] [Related]

  • 15. Warnings on venous thromboembolism risks may have been premature. New data may lead to change in use of third-generation OCs.
    Contracept Technol Update; 1997 Dec 12; 18(12):145-8. PubMed ID: 12348219
    [Abstract] [Full Text] [Related]

  • 16. The differential risk of oral contraceptives: the impact of full exposure history.
    Lewis MA, MacRae KD, Kühl-Habichl D, Bruppacher R, Heinemann LA, Spitzer WO.
    Hum Reprod; 1999 Jun 12; 14(6):1493-9. PubMed ID: 10359554
    [Abstract] [Full Text] [Related]

  • 17. Another pill scare -- should we audit its impact?
    Bromham DR.
    Audit Unit News; 1996 Jan 12; 1(4):2-3. PubMed ID: 12346948
    [Abstract] [Full Text] [Related]

  • 18. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
    Contracept Rep; 1994 Mar 12; 5(1):10-3. PubMed ID: 12287738
    [Abstract] [Full Text] [Related]

  • 19. Contraceptive choices in women with coagulation disorders.
    Comp PC, Zacur HA.
    Am J Obstet Gynecol; 1993 Jun 12; 168(6 Pt 2):1990-3. PubMed ID: 8512043
    [Abstract] [Full Text] [Related]

  • 20. Effect of the British warning on contraceptive use in the General Medical Service in Ireland.
    Williams D, Kelly A, Carvalho M, Feely J.
    Ir Med J; 1998 Dec 12; 91(6):202-3. PubMed ID: 10069128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.